Flow Bone: Is This New Bone Drug Really Worth the Hype?
A lot of people have been asking about a new European experiment called Flow Bone—and ...
What Happens When You Stop Bone Drugs? (+ What to Do)
What Happens When You Stop Bone Drugs?
Bone-building medications often seem like a quick fix, giving many women ...
Prolia for Bone Fractures — I’m Still Not Impressed
When the bone drug Prolia (denosumab) first came out in 2010, I took a hard look at it because it used a ...
Forteo®, Tymlos® and Evenity®: How Much Do They Really Reduce Fracture Risk?
The latest crop of recent bone drugs contains new anabolic drugs that enhance bone density. These drugs are ...
Forteo for osteoporosis — is this bone drug too good to be true?
Forteoâ„¢ (teriparatide) is a new and different drug on the scene as a treatment for osteoporosis. Other bone drugs, ...
6 ways standard osteoporosis treatment is dead wrong: Part 3
In my previous two blogs, I’ve given you 4 important reasons why I don’t believe standard osteoporosis treatment ...
6 ways standard osteoporosis treatment is dead wrong: Part 2
I’ve written recently about two of my top six concerns about the standard approach to bone health. And now, here ...
6 ways standard osteoporosis treatment is dead wrong: Part 1
It’s no secret that I’m not a fan of the way bone drugs like Prolia® and Fosamax® are used these days. But people ...
Bone density measurements were never meant to be treatment guidelines
For years we have known that bone density does not itself predict fracture, yet how many men and women have been ...
What do I really think of osteoporosis drugs, anyway?
Those of you who read this blog and my articles regularly might think I’m against osteoporosis drugs altogether. ...
The next big bone drug: big bang or little whimper? 5 questions to ask when evaluating bone building drugs
The next big new bone building drug has hit your doctor’s office. Impressive claims that the drug reduces ...
A look at the latest bone drug, Evenity
In April 2019, the FDA approved romosozumab (Evenity), a new osteoporosis drug targeted at postmenopausal women ...
No results found.